¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Journal of cutaneous laser therapy."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • systemic therapy
    Àü½Å¿ä¹ý
  • therapy
    ¿ä¹ý
  • thrombolytic therapy
    Ç÷Àü¿ëÇØ¿ä¹ý
  • topical therapy
    ±¹¼Ò¿ä¹ý
  • ultrasonic therapy
    (¢¡ultrasound therapy) ÃÊÀ½ÆÄ¿ä¹ý
  • ultrasound therapy
    ÃÊÀ½ÆÄ¿ä¹ý
  • vaccine therapy
    ¹é½Å¿ä¹ý
  • will therapy
    ÀÇÁö¿ä¹ý
  • work therapy
    ÀÛ¾÷¿ä¹ý
  • work stimulation therapy
    ÀÛ¾÷Àڱؿä¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • cutaneous sensation
    ÇǺΰ¨°¢(ù«Ý±ÊïÊÆ).
  • cutaneous sense
    ÇǺΰ¨°¢.
  • cutaneous spot
    ÇǺιÝ(Á¡)
  • cutaneous subacute lupus
    ÇǺΠ¾Æ±Þ¼º ·çǪ½º
  • cutaneous sulci
    ÇǺΰí¶û
  • cutaneous sulcus
    ÇǺΠ°í¶û
  • cutaneous symptom
    ÇǺÎÁõ»ó
  • cutaneous symptoms
    ÇǺÎÁõ»ó.
  • cutaneous syphilis
    ÇǺθŵ¶(¡­ØÞÔ¸).
  • cutaneous syphilis
    ÇǺθŵ¶(¡­ØÞÔ¸)
  • cutaneous systemic vasculitis
    ÇǺΠÀü½Å¼º(ù«Ý± îïãóàõ) Ç÷°ü¿°(úìηæú)
  • cutaneous t cell lymphoma
    ÇǺΠT ¼¼Æ÷¸²ÇÁÁ¾(ù«Ý±¡­ðþ)
  • cutaneous tag
    ÇǺο¬¼º¼¶À¯Á¾
  • cutaneous tumor
    ÇǺÎÁ¾¾ç
  • cutaneous ureteroileostomy
    ÇǺοä°üȸÀå ¹®ÇÕ¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
SLAM scanning laser acoustic microscope; systemic lupus erythematosus activity measure
TULIP transurethral ultrasound-guided laser-induced prostatectomy
YAG yttrium aluminum garnet [laser]
LMS Laser microscopic surgery
CTCL Cutaneous T Cell Lymphoma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
LASIK LASer In situ Keratomileusis
LAUP Laser assisted uvulopalatoplasty
LCM Laser Capture Microdissection
LD Laser Doppler
LDA Laser Doppler Anemometer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • music therapy
    À½¾Ç ¿ä¹ý
  • non-reversible therapy
    ºñ°¡¿ªÀûÀÎ Ä¡·á
  • nonvital pulp therapy technique
    ½ÇȰ Ä¡¼ö Ä¡·á ¼ú½Ä
  • occlusal splint therapy
    ±³ÇÕ ÀåÄ¡ ¿ä¹ý
  • occlusal therapy
    ±³ÇÕ Ä¡·á
  • occupational therapy
    ÀÛ¾÷ ¿ä¹ý
    Ä¡·á ¸ñÀûÀ» À§ÇÑ ÀÛ¾÷ÀÇ Àû¿ë.
  • palliative therapy
    °í½ÄÀû Ä¡·á
  • prosthodontic therapy
    º¸Ã¶ Ä¡·á
  • radiation therapy
    ¹æ»ç¼± Ä¡·á
    °í¿¡³ÊÁö ¹æ»ç¼±À¸·Î ¾Ï ¼¼Æ÷¸¦ Á×À̰ųª ¼Õ»ó½ÃŰ´Â Ä¡·á¹ý. ¿ÜºÎ ¹æ»ç¼± Ä¡·á´Â °í¿¡³ÊÁö ¹æ»ç¼±À» ü¿Ü¿¡¼­ ¾Ï¿¡ Á¶ÁØÇÏ¿© ÂÉÀÌ´Â °ÍÀÌ´Ù. ³»ºÎ ¹æ»ç¼± Ä¡·á´Â ¹æ»ç¼º ¹°ÁúÀ» ü³» ¾Ï °¡±î¿î °÷¿¡ ³Ö¾î Ä¡·áÇÏ´Â °ÍÀÌ´Ù.
  • radioactive iodine therapy
    ¹æ»ç¼± Ȱ¼º ¿ä¿Àµå Ä¡·á
  • reality therapy
    Çö½Ç Ä¡·á
  • rehabilitative therapy
    ÀçÆÈ ¿ä¹ý
  • reversible occlusal therapy
    °¡¿ªÀûÀÎ ±³ÇÕ Ä¡·á, °¡¿ªÀû ±³ÇÕ Ä¡·á
  • sero therapy
    Ç÷û ¿ä¹ý
    ¼¼Æ÷ °¨¿°Áõ °¡¿îµ¥ ¿Üµ¶¼Ò¿¡ ÀÇÇØ »ý±â´Â ÁúȯÀ̳ª ¹ìÀÇ ±³ÁõÀ» Ä¡·áÇÏ´Â ¹æ¹ý Áß ÇϳªÀÌ´Ù.
  • solid carbon dioxide therapy
    °íü ź»ê °¡½º ¿ä¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
lymphoma, T-cell, cutaneous A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. Mycosis fungoides and sezary syndrome are the best characterised of these disorders.
(12 Dec 1998)
acupuncture therapy Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. Heat or moxibustion and acupressure may be used in conjunction.
(12 Dec 1998)
adjuvant therapy <oncology, pharmacology> Treatment that is added to increase the effectiveness of a primary treatment. In cancer, adjuvant treatment usually refers to chemotherapy, hormonal therapy or radiation therapy after surgery to increase the likelihood of killing all cancer cells.
(14 May 1997)
alternative therapy A term given to nonconventional therapy usually given by persons who do not have a medical qualification.
(16 Dec 1997)
analytic therapy Short term for psychoanalytic therapy.
(05 Mar 2000)
Antibody Directed Enzyme Prodrug Therapy <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately.
The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects.
Acronym: ADEPT
(14 Nov 1997)
anticoagulant therapy The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting.
(05 Mar 2000)
antisense therapy Use of antisense DNA for the inhibition of translation of a specific gene product for therapeutic purposes.
(05 Mar 2000)
art therapy The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioural disorders.
(12 Dec 1998)
autoserum therapy Therapy with serum obtained from the patient's own blood.
(05 Mar 2000)
aversion therapy <psychology> A form of behaviour therapy that pairs an unpleasant stimulus with undesirable behaviour(s) so that the patient learns to avoid the latter.
See: aversive training.
(05 Mar 2000)
aversive therapy <psychology> A treatment that suppresses undesirable behaviour by simultaneously exposing the subject to unpleasant consequences.
(12 Dec 1998)
behaviour therapy The application of modern theories of learning and conditioning in the treatment of behaviour disorders.
(12 Dec 1998)
biological therapy <oncology> Treatment with substances that can stimulate the immune system to fight disease more effectively.
Synonym: immunotherapy.
(16 Dec 1997)
boron neutron capture therapy A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á